Vector Science and Therapeutics Corp.
PAIN.V
TSX
| 02/28/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -95.57% | ||||
| Gross Profit | 95.57% | ||||
| SG&A Expenses | -38.27% | ||||
| Depreciation & Amortization | 26.92% | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -70.69% | ||||
| Operating Income | 70.69% | ||||
| Income Before Tax | 75.59% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | 75.59% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 75.59% | ||||
| EBIT | 70.69% | ||||
| EBITDA | 71.00% | ||||
| EPS Basic | 75.84% | ||||
| Normalized Basic EPS | 75.84% | ||||
| EPS Diluted | 75.84% | ||||
| Normalized Diluted EPS | 75.84% | ||||
| Average Basic Shares Outstanding | 1.01% | ||||
| Average Diluted Shares Outstanding | 1.01% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||